PIAS3 and prostate adenocarcinoma: Additionally, a prediction model consisted of PIAS3-7292-RI, RFFL-40233-ES, CCDC74A-55385-AT, TMEM205-47,661-ES and TIMM50-49,835-ES was a successful forecast model for prognosis of PRAD patients, which had a high prediction accuracy.